Skip to main content

Table 2 Serum concentrations of CA-125, TIMP-1 and VEGF at different time-points during therapy

From: TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients

 

Before surgery

After surgery/before CTX

during CTX

after CTX

 

mean

median

range

mean

median

range

mean

median

range

mean

median

range

CA-125 [kU/L]

1948

413

20-20880

325

84

15-5965

113

21

6-2562

72

15

5-1429

TIMP-1 [ng/mL]

451

403

273-887

573

529

323-1000

377

351

204-616

371

333

209-990

VEGF [pg/mL]

231

171

25-791

355

272

85-1133

176

139

11-558

192

147

11-960